Migraine in Children Recruiting Phase 3 Trials for Lidocaine (DB00281)

IndicationStatusPhase
DBCOND0116907 (Migraine in Children)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03984045SPG Block for Acute Pediatric MigraineTreatment